FindTrial
Sign In

Cocaine Abuse and Attention Deficit Disorder - 3

Cocaine Abuse and Attention Deficit Disorder

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00000268
Enrollment
32
Registered
1999-09-21
Start date
1995-05-31
Completion date
1998-11-30
Last updated
2017-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cocaine-Related Disorders

Keywords

cocaine dependence

Brief summary

The purpose of this study is to evaluate cocaine abuse and Attention Deficit Disorder

Detailed description

To evaluate the safety and efficacy of methylphenidate and bupropion in treating individuals with adult Attention Deficit Disorder.

Interventions

DRUGBupropion

Sponsors

New York State Psychiatric Institute
CollaboratorOTHER
National Institute on Drug Abuse (NIDA)
Lead SponsorNIH

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

current adult ADHD current cocaine dependence

Exclusion criteria

no current major depression

Design outcomes

Primary

MeasureTime frame
Side effects—
Craving—
Drug use—
ADHD symptoms—
Improvement in functioning—
Tolerability—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026